<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38116398</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1662-5102</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in cellular neuroscience</Title><ISOAbbreviation>Front Cell Neurosci</ISOAbbreviation></Journal><ArticleTitle>Human motor neurons derived from induced pluripotent stem cells are susceptible to SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>1285836</StartPage><MedlinePgn>1285836</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1285836</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fncel.2023.1285836</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">COVID-19 typically causes Q7 respiratory disorders, but a high proportion of patients also reports neurological and neuromuscular symptoms during and after SARSCoV-2 infection. Despite a number of studies documenting SARS-CoV-2 infection of various neuronal cell populations, the impact of SARS-CoV-2 exposure on motor neuronal cells specifically has not been investigated so far.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Thus, by using human iPSC-derived motor neurons (iPSC-MNs) we assessed: (i) the expression of SARS-CoV-2 main receptors; (ii) iPSC-MN infectability by SARS-CoV-2; and (iii) the effect of SARS-CoV-2 exposure on iPSC-MN transcriptome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Gene expression profiling and immunofluorescence (IF) analysis of the main host cell receptors recognized by SARS-CoV-2 revealed that all of them are expressed in iPSC-MNs, with CD147 and NRP1 being the most represented ones. By analyzing SARS-CoV-2 N1 and N2 gene expression over time, we observed that human iPSC-MNs were productively infected by SARS-CoV-2 in the absence of cytopathic effect. Supernatants collected from SARS-CoV-2-infected iPSC-MNs were able to re-infect VeroE6 cells. Image analyses of SARS-CoV-2 nucleocapsid proteins by IF confirmed iPSC-MN infectability. Furthermore, SARS-CoV-2 infection in iPSCMNs significantly altered the expression of genes (IL-6, ANG, S1PR1, BCL2, BAX, Casp8, HLA-A, ERAP1, CD147, MX1) associated with cell survival and metabolism, as well as antiviral and inflammatory response.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">These results suggest for the very first time that SARS-CoV-2 can productively infect human iPSC-derived MNs probably by binding CD147 and NRP1 receptors. Such information will be important to unveil the biological bases of neuromuscular disorders characterizing SARS-CoV-2 infection and the so called long-COVID symptoms.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Cappelletti, Colombrita, Limanaqi, Invernizzi, Garziano, Vanetti, Moscheni, Santangelo, Zecchini, Trabattoni, Silani, Clerici, Ratti and Biasin.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cappelletti</LastName><ForeName>Gioia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Immune-Biology, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombrita</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Limanaqi</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory of Immune-Biology, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Immunology, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Invernizzi</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garziano</LastName><ForeName>Micaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Immune-Biology, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Immunology, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanetti</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Immune-Biology, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moscheni</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Immune-Biology, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santangelo</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Translational Medicine, Aldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zecchini</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Immune-Biology, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trabattoni</LastName><ForeName>Daria</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory of Immune-Biology, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silani</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clerici</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Immunology, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Don C. Gnocchi Foundation, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Foundation, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratti</LastName><ForeName>Antonia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Translational Medicine, Aldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biasin</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Immune-Biology, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Neurosci</MedlineTA><NlmUniqueID>101477935</NlmUniqueID><ISSNLinking>1662-5102</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">iPSC-derived motor neurons</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">neuromuscular disorders</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>20</Day><Hour>4</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38116398</ArticleId><ArticleId IdType="pmc">PMC10728732</ArticleId><ArticleId IdType="doi">10.3389/fncel.2023.1285836</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abu-Rumeileh S., Abdelhak A., Foschi M., Tumani H., Otto M. (2021). Guillain&#x2013;Barr&#xe9; syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J. Neurol. 268 1133&#x2013;1170. 10.1007/s00415-020-10124-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10124-x</ArticleId><ArticleId IdType="pmc">PMC7445716</ArticleId><ArticleId IdType="pubmed">32840686</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti P., Beretta S., Piatti M., Karantzoulis A., Piatti M., Santoro P., et al. (2020). Guillain-Barr&#xe9; syndrome related to COVID-19 infection. Neurol. Neuroimmunol. Neuroinflamm. 7 e741. 10.5005/jp-journals-10071-23723</Citation><ArticleIdList><ArticleId IdType="doi">10.5005/jp-journals-10071-23723</ArticleId><ArticleId IdType="pmc">PMC7217652</ArticleId><ArticleId IdType="pubmed">32350026</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand H., Ende V., Singh G., Qureshi I., Duong T., Mehler M. (2021). Nervous system-systemic crosstalk in SARS-CoV-2/COVID-19: A unique dyshomeostasis syndrome. Front. Neurosci. 15:727060. 10.3389/fnins.2021.727060</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.727060</ArticleId><ArticleId IdType="pmc">PMC8430330</ArticleId><ArticleId IdType="pubmed">34512253</ArticleId></ArticleIdList></Reference><Reference><Citation>Andalib S., Biller J., Di Napoli M., Moghimi N., McCullough L., Rubinos C., et al. (2021). Peripheral nervous system manifestations associated with COVID-19. Curr. Neurol. Neurosci. Rep. 21:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7882462</ArticleId><ArticleId IdType="pubmed">33586020</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardelli D., Sassone F., Colombrita C., Volpe C., Gumina V., Peverelli S., et al. (2020). Reprogramming fibroblasts and peripheral blood cells from a C9ORF72 patient: A proof-of-principle study. J. Cell Mol. Med. 24 4051&#x2013;4060. 10.1111/jcmm.15048</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15048</ArticleId><ArticleId IdType="pmc">PMC7171411</ArticleId><ArticleId IdType="pubmed">32125773</ArticleId></ArticleIdList></Reference><Reference><Citation>Bizzotto J., Sanchis P., Abbate M., Lage-Vickers S., Lavignolle R., Toro A., et al. (2020). SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients. iScience 23:101585. 10.1016/j.isci.2020.101585</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101585</ArticleId><ArticleId IdType="pmc">PMC7510433</ArticleId><ArticleId IdType="pubmed">32989429</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossolasco P., Sassone F., Gumina V., Peverelli S., Garzo M., Silani V. (2018). Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient. Stem Cell Res. 30 61&#x2013;68. 10.1016/j.scr.2018.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2018.05.009</ArticleId><ArticleId IdType="pubmed">29800782</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L., Ojha R., Pedro L., Djannatian M., Franz J., Kuivanen S., et al. (2020). Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370 856&#x2013;860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Caress J., Castoro R., Simmons Z., Scelsa S., Lewis R., Ahlawat A., et al. (2020). COVID-19&#x2013;ASSOCIATED GUILLAIN-BARR&#xc9; syndrome: The early pandemic experience. Muscle Nerve 62 485&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405390</ArticleId><ArticleId IdType="pubmed">32678460</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A. Bernabei R. Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. (2020). Persistent symptoms in patients after acute COVID-19. JAMA 324 603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhry M., Casalegno-Garduno R., Sitnik K., Kasmapour B., Pulm A., Brizic I., et al. (2020). Cytomegalovirus inhibition of extrinsic apoptosis determines fitness and resistance to cytotoxic CD8 T cells. Proc. Natl. Acad. Sci. U. S. A. 117 12961&#x2013;12968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7293702</ArticleId><ArticleId IdType="pubmed">32444487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Wu D., Chen H., Yan W., Yang D., Chen G., et al. (2020). Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368 m1091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou S., Beghi E., Helbok R., Moro E., Sampson J., Altamirano V., et al. (2021). Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19&#x2014;A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw. Open 4 e2112131. 10.1001/jamanetworkopen.2021.12131</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.12131</ArticleId><ArticleId IdType="pmc">PMC8114143</ArticleId><ArticleId IdType="pubmed">33974053</ArticleId></ArticleIdList></Reference><Reference><Citation>Coomes E., Haghbayan H. (2020). Interleukin-6 in Covid-19: A systematic review and meta-analysis. Rev. Med. Virol. 30 1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7460877</ArticleId><ArticleId IdType="pubmed">32845568</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutard B., Valle C., de Lamballerie X., Canard B., Seidah N., Decroly E. (2020). The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir. Res. 176:104742. 10.1016/j.antiviral.2020.104742</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2020.104742</ArticleId><ArticleId IdType="pmc">PMC7114094</ArticleId><ArticleId IdType="pubmed">32057769</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly J., Simonetti B., Klein K., Chen K., Williamson M., Ant&#xf3;n-Pl&#xe1;garo C., et al. (2020). Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370 861&#x2013;865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612957</ArticleId><ArticleId IdType="pubmed">33082294</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H., Assaf G., McCorkell L., Wei H., Low R., Re&#x2019;em Y., et al. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Dusaban S., Chun J., Rosen H., Purcell N., Brown J. (2017). Sphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes. J. Neuroinflammation 14:111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5455202</ArticleId><ArticleId IdType="pubmed">28577576</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenizia C., Biasin M., Cetin I., Vergani P., Mileto D., Spinillo A., et al. (2020). Analysis of SARS-CoV-2 vertical transmission during pregnancy. Nat. Commun. 11:5128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7552412</ArticleId><ArticleId IdType="pubmed">33046695</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenizia C., Galbiati S., Vanetti C., Vago R., Clerici M., Tacchetti C., et al. (2021). SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2. Cells 10:1434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8226513</ArticleId><ArticleId IdType="pubmed">34201214</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenizia C., Galbiati S., Vanetti C., Vago R., Clerici M., Tacchetti C., et al. (2022). Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants. Microbiol. Spectr. 10 e0150421. 10.1128/spectrum.01504-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01504-21</ArticleId><ArticleId IdType="pmc">PMC8729790</ArticleId><ArticleId IdType="pubmed">34985303</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci R., Dini M., Rosci C., Capozza A., Groppo E., Reitano M., et al. (2022). One-year cognitive follow-up of COVID-19 hospitalized patients. Euro. J. Neurol. 29 2006&#x2013;2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111730</ArticleId><ArticleId IdType="pubmed">35285122</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y., Xu H., Liu S. J. (2022). COVID-19 and neurodegenerative diseases. Eur. Rev. Med. Pharmacol. Sci. 26 4535&#x2013;4544.</Citation><ArticleIdList><ArticleId IdType="pubmed">35776055</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., et al. (2020). Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 81 e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Gugliandolo A., Chiricosta L., Calcaterra V., Biasin M., Cappelletti G., Carelli S., et al. (2021). SARS-CoV-2 infected pediatric cerebral cortical neurons: Transcriptomic analysis and potential role of toll-like receptors in pathogenesis. IJMS 22:8059. 10.3390/ijms22158059</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22158059</ArticleId><ArticleId IdType="pmc">PMC8347089</ArticleId><ArticleId IdType="pubmed">34360824</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumina V., Colombrita C., Fallini C., Bossolasco P., Maraschi A., Landers J., et al. (2019). TDP-43 and NOVA-1 RNA-binding proteins as competitive splicing regulators of the schizophrenia-associated TNIK gene. Biochim. Biophys. Acta Gene Regul. Mech. 1862:194413. 10.1016/j.bbagrm.2019.194413</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagrm.2019.194413</ArticleId><ArticleId IdType="pmc">PMC7818381</ArticleId><ArticleId IdType="pubmed">31382054</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller O., Arnheiter H., Pavlovic J., Staeheli P. (2018). The discovery of the antiviral resistance gene Mx: A story of great ideas, great failures, and some success. Annu. Rev. Virol. 5 33&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">29958082</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller O., Kochs G. (2020). Mx genes: host determinants controlling influenza virus infection and trans-species transmission. Hum. Genet. 139 695&#x2013;705. 10.1007/s00439-019-02092-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-019-02092-8</ArticleId><ArticleId IdType="pmc">PMC7087808</ArticleId><ArticleId IdType="pubmed">31773252</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M., Lely A., Navis G., van Goor H. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203 631&#x2013;637. 10.1002/path.1570</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper L., Stappenbeck T., Hong C., Gordon J. (2003). Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4 269&#x2013;273. 10.1038/ni888</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni888</ArticleId><ArticleId IdType="pubmed">12548285</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397 220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob S., Kapadia R., Soule T., Luo H., Schellenberg K., Douville R., et al. (2022). Neuromuscular Complications of SARS-CoV-2 and Other Viral Infections. Front. Neurol. 13:914411. 10.3389/fneur.2022.914411</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.914411</ArticleId><ArticleId IdType="pmc">PMC9263266</ArticleId><ArticleId IdType="pubmed">35812094</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaywant A., Vanderlind W., Alexopoulos G., Fridman C., Perlis R., Gunning F. (2021). Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology 46 2235&#x2013;2240. 10.1038/s41386-021-00978-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-021-00978-8</ArticleId><ArticleId IdType="pmc">PMC7884062</ArticleId><ArticleId IdType="pubmed">33589778</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonji&#x107; S., Babi&#x107; M., Poli&#x107; B., Krmpoti&#x107; A. (2008). Immune evasion of natural killer cells by viruses. Curr. Opin. Immunol. 20 30&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700287</ArticleId><ArticleId IdType="pubmed">18206359</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce J., Moore G., Goswami P., Harrell T., Taylor T., Hawks S., et al. (2022). SARS-CoV-2 infects peripheral and central neurons before viremia, facilitated by neuropilin-1. bioRxiv [Preprint]. 10.1101/2022.05.20.492834</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.20.492834</ArticleId></ArticleIdList></Reference><Reference><Citation>Kathuria A., Lopez-Lengowski K., Watmuff B., Karmacharya R. (2020). Comparative transcriptomic analysis of cerebral organoids and cortical neuron cultures derived from human induced pluripotent stem cells. Stem Cells Dev. 29 1370&#x2013;1381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7698857</ArticleId><ArticleId IdType="pubmed">32862797</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettunen P., Lesnikova A., R&#xe4;s&#xe4;nen N., Ojha R., Palmunen L., Laakso M., et al. (2023). SARS-CoV-2 infection of human neurons is TMPRSS2 independent, requires endosomal cell entry, and can be blocked by inhibitors of host phosphoinositol-5 kinase. J. Virol. 97 e0014423. 10.1128/jvi.00144-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00144-23</ArticleId><ArticleId IdType="pmc">PMC10134833</ArticleId><ArticleId IdType="pubmed">37039676</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Heo J., Kim H., Song S. H., Park S., Park T., et al. (2017). Neurological complications during treatment of middle east respiratory syndrome. J. Clin. Neurol. 13:227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5532318</ArticleId><ArticleId IdType="pubmed">28748673</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein R., Soung A., Sissoko C., Nordvig A., Canoll P., Mariani M., et al. (2021). COVID-19 induces neuroinflammation and loss of hippocampal neurogenesis [Internet]. Res. Sq. 3:1031824.</Citation></Reference><Reference><Citation>Koralnik I., Tyler K. (2020). COVID-19: A global threat to the nervous system. Ann. Neurol. 88 1&#x2013;11. 10.1002/ana.25807</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25807</ArticleId><ArticleId IdType="pmc">PMC7300753</ArticleId><ArticleId IdType="pubmed">32506549</ArticleId></ArticleIdList></Reference><Reference><Citation>Kummer K., Zeidler M., Kalpachidou T., Kress M. (2021). Role of IL-6 in the regulation of neuronal development, survival and function. Cytokine 144:155582.</Citation><ArticleIdList><ArticleId IdType="pubmed">34058569</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Zhang Y., Guan Z., Li H., Ye M., Chen X., et al. (2020). SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation. Sig. Transduct. Target Ther. 5:235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7545816</ArticleId><ArticleId IdType="pubmed">33037188</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Lu S., Gu J., Xia W., Zhang S., Zhang S., et al. (2022). SARS-CoV-2 impairs the disassembly of stress granules and promotes ALS-associated amyloid aggregation. Protein Cell 13 602&#x2013;614. 10.1007/s13238-022-00905-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-022-00905-7</ArticleId><ArticleId IdType="pmc">PMC8983322</ArticleId><ArticleId IdType="pubmed">35384603</ArticleId></ArticleIdList></Reference><Reference><Citation>Limanaqi F., Zecchini S., Dino B., Strizzi S., Cappelletti G., Utyro O., et al. (2022). Dopamine reduces SARS-CoV-2 replication in vitro through downregulation of D2 receptors and upregulation of type-i interferons. Cells 11:1691. 10.3390/cells11101691</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11101691</ArticleId><ArticleId IdType="pmc">PMC9139638</ArticleId><ArticleId IdType="pubmed">35626728</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez G., Tonello C., Osipova G., Carsana L., Biasin M., Cappelletti G., et al. (2022). Olfactory bulb SARS-CoV-2 infection is not paralleled by the presence of virus in other central nervous system areas. Neuropathol. Appl. Neurobiol. 48:12752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447476</ArticleId><ArticleId IdType="pubmed">34297438</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou J., Movassaghi M., Gordy D., Olson M., Zhang T., Khurana M., et al. (2021). Neuropathology of COVID-19 (neuro-COVID): clinicopathological update. Free Neuropathol. 2:2. 10.17879/freeneuropathology-2021-2993</Citation><ArticleIdList><ArticleId IdType="doi">10.17879/freeneuropathology-2021-2993</ArticleId><ArticleId IdType="pmc">PMC7861505</ArticleId><ArticleId IdType="pubmed">33554218</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons-Weiler J. (2020). Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. J. Transl. Autoimmunity 3:100051. 10.1016/j.jtauto.2020.100051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2020.100051</ArticleId><ArticleId IdType="pmc">PMC7142689</ArticleId><ArticleId IdType="pubmed">32292901</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyoo K., Kim H., Lee B., Che Y., Kim S., Song D., et al. (2022). Direct neuronal infection of SARS-CoV-2 reveals cellular and molecular pathology of chemosensory impairment of COVID-19 patients. Emerg. Microb. Infect. 11 407&#x2013;412. 10.1080/22221751.2021.2024095</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.2024095</ArticleId><ArticleId IdType="pmc">PMC8803065</ArticleId><ArticleId IdType="pubmed">34962444</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini M., Vidal S. (2020). Mechanisms of Natural Killer Cell Evasion Through Viral Adaptation. Annu. Rev. Immunol. 38 511&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">32340578</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., et al. (2020). Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 77:683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Marfia G., Navone S., Guarnaccia L., Campanella R., Mondoni M., Locatelli M., et al. (2021). Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19. EMBO Mol. Med. 13 e13424. 10.15252/emmm.202013424</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202013424</ArticleId><ArticleId IdType="pmc">PMC7744841</ArticleId><ArticleId IdType="pubmed">33190411</ArticleId></ArticleIdList></Reference><Reference><Citation>Meacci E., Garcia-Gil M., Pierucci F. (2020). SARS-CoV-2 Infection: A role for S1P/S1P receptor signaling in the nervous system? Int. J. Mol. Sci. 21:6773. 10.3390/ijms21186773</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21186773</ArticleId><ArticleId IdType="pmc">PMC7556035</ArticleId><ArticleId IdType="pubmed">32942748</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez R., Balanz&#xe1;-Mart&#xed;nez V., Luperdi S., Estrada I., Latorre A., Gonz&#xe1;lez-Jim&#xe9;nez P. (2021). Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors. J Intern. Med. 290 621&#x2013;631. 10.1111/joim.13262</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13262</ArticleId><ArticleId IdType="pmc">PMC8013333</ArticleId><ArticleId IdType="pubmed">33533521</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalvan V., Lee J., Bueso T., De Toledo J., Rivas K. (2020). Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin. Neurol. Neurosurg. 194:105921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227498</ArticleId><ArticleId IdType="pubmed">32422545</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhammed L., Baheerathan A., Cao M., Leite M., Viegas S. (2021). MuSK Antibody&#x2013;Associated Myasthenia Gravis With SARS-CoV-2 Infection: A Case Report. Ann. Intern. Med. 174 872&#x2013;873. 10.7326/L20-1298</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/L20-1298</ArticleId><ArticleId IdType="pmc">PMC7808439</ArticleId><ArticleId IdType="pubmed">33428437</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahalkova J., Volkmann I., Aoki M., Winblad B., Bogdanovic N., Tjernberg L., et al. (2010). CD147, a &#x3b3;-secretase associated protein is upregulated in Alzheimer&#x2019;s disease brain and its cellular trafficking is affected by presenilin-2. Neurochem. Int. 56 67&#x2013;76. 10.1016/j.neuint.2009.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2009.09.003</ArticleId><ArticleId IdType="pubmed">19751784</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M., McGroder C., Stevens J., et al. (2021). Post-acute COVID-19 syndrome. Nat. Med. 27 601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nampoothiri S., Sauve F., Ternier G., Fernandois D., Coelho C., Imbernon M., et al. (2020). The hypothalamus as a hub for SARS-CoV-2 brain infection and pathogenesis. bioRxiv [Preprint]. 10.1101/2020.06.08.139329</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.08.139329</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G., Trolese M., Bendotti C. (2016). Major Histocompatibility Complex I Expression by Motor Neurons and Its Implication in Amyotrophic Lateral Sclerosis. Front. Neurol. 13:89. 10.3389/fneur.2016.00089</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2016.00089</ArticleId><ArticleId IdType="pmc">PMC4904147</ArticleId><ArticleId IdType="pubmed">27379008</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham E., Newcombe V., Michell A., Thornton R., Grainger A., Anwar F., et al. (2020). Mononeuritis multiplex: an unexpectedly common feature of severe COVID-19. medRxiv [Preprint]. 10.1101/2020.07.19.20149898</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.19.20149898</ArticleId><ArticleId IdType="pmc">PMC7690651</ArticleId><ArticleId IdType="pubmed">33244712</ArticleId></ArticleIdList></Reference><Reference><Citation>Niazkar H., Zibaee B., Nasimi A., Bahri N. (2020). The neurological manifestations of COVID-19: a review article. Neurol. Sci. 41 1667&#x2013;1671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262683</ArticleId><ArticleId IdType="pubmed">32483687</ArticleId></ArticleIdList></Reference><Reference><Citation>Noschka R., Gerbl F., L&#xf6;ffler F., Kubis J., Rodr&#xed;guez A., Mayer D., et al. (2021). Unbiased identification of angiogenin as an endogenous antimicrobial protein with activity against virulent mycobacterium tuberculosis. Front. Microbiol. 11:618278. 10.3389/fmicb.2020.618278</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.618278</ArticleId><ArticleId IdType="pmc">PMC7848861</ArticleId><ArticleId IdType="pubmed">33537017</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan S., O&#x2019;Sullivan C., Healy L., Dev K., Sheridan G. (2018). Sphingosine 1-phosphate receptors regulate TLR4-induced CXCL5 release from astrocytes and microglia. J. Neurochem. 144 736&#x2013;747. 10.1111/jnc.14313</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14313</ArticleId><ArticleId IdType="pubmed">29377126</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., et al. (2020). Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun. 11:1620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7100515</ArticleId><ArticleId IdType="pubmed">32221306</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini L., Albecka A., Mallery D., Kellner M., Paul D., Carter A., et al. (2020). SARS-CoV-2 infects the brain choroid plexus and disrupts the blood-CSF barrier in human brain organoids. Cell Stem Cell 27 951&#x2013;961. 10.1016/j.stem.2020.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7553118</ArticleId><ArticleId IdType="pubmed">33113348</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A., Padovani A. (2020). Lifting the mask on neurological manifestations of COVID-19. Nat. Rev. Neurol. 16 636&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7444680</ArticleId><ArticleId IdType="pubmed">32839585</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Cristillo V., Cotti Piccinelli S., Zoppi N., Bonzi G., Sattin D., et al. (2021). Long-term neurological manifestations of COVID-19: prevalence and predictive factors. Neurol. Sci. 42 4903&#x2013;4907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8439956</ArticleId><ArticleId IdType="pubmed">34523082</ArticleId></ArticleIdList></Reference><Reference><Citation>Piras M., Cau F., Manchia M., Paribello P., Saba L., Suri J., et al. (2022). Strong ACE-2 expression in the choroidal vessels: do high choroid plexuses serve as a gateway for SARS-CoV-2 infection on the human brain? Eur. Rev. Med. Pharmacol. Sci. 26 3025&#x2013;3029. 10.26355/eurrev_202204_28633</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202204_28633</ArticleId><ArticleId IdType="pubmed">35503602</ArticleId></ArticleIdList></Reference><Reference><Citation>Pleguezuelos E., Del Carmen A., Llorensi G., Carcole J., Casarramona P., Moreno E., et al. (2021). Severe loss of mechanical efficiency in COVID-19 patients. J. Cach. Sarcop. Muscle 12 1056&#x2013;1063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242734</ArticleId><ArticleId IdType="pubmed">34102017</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao J., Li W., Bao J., Peng Q., Wen D., Wang J., et al. (2020). The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues. Biochem. Biophys. Res. Commun. 533 867&#x2013;871. 10.1016/j.bbrc.2020.09.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.09.042</ArticleId><ArticleId IdType="pmc">PMC7489930</ArticleId><ArticleId IdType="pubmed">33008593</ArticleId></ArticleIdList></Reference><Reference><Citation>Raahimi M., Kane A., Moore C., Alareed A. (2021). Late onset of Guillain-Barr&#xe9; syndrome following SARS-CoV-2 infection: part of &#x2018;long COVID-19 syndrome&#x2019;? BMJ Case Rep. 14 e240178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7813388</ArticleId><ArticleId IdType="pubmed">33462068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani A., M&#xfc;ller L., Ostermann P., Gabriel E., Abida-Islam P., M&#xfc;ller-Schiffmann A., et al. (2020). SARS -CoV-2 targets neurons of 3D human brain organoids. EMBO J. 39:6230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7560208</ArticleId><ArticleId IdType="pubmed">32876341</ArticleId></ArticleIdList></Reference><Reference><Citation>Restivo D., Centonze D., Alesina A., Marchese-Ragona R. (2020). Myasthenia Gravis Associated With SARS-CoV-2 Infection. Ann. Intern. Med. 173 1027&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429993</ArticleId><ArticleId IdType="pubmed">32776781</ArticleId></ArticleIdList></Reference><Reference><Citation>Samudyata S., Oliveira A., Malwade S., de Sousa N., Goparaju S., Orhan F., et al. (2021). SARS-CoV-2 neurotropism and single cell responses in brain organoids containing innately developing microglia. bioRxiv [Preprint]. 10.1101/2021.07.07.451463</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.07.451463</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Castro P., Estivill-Torr&#xfa;s G., Cabezudo-Garc&#xed;a P., Reyes-Bueno J., Ciano Petersen N., Aguilar-Castillo M., et al. (2020). Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: A delayed pandemic? Neurolog&#xed;a 35 245&#x2013;251. 10.1016/j.nrl.2020.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2020.04.002</ArticleId><ArticleId IdType="pmc">PMC7164900</ArticleId><ArticleId IdType="pubmed">32364119</ArticleId></ArticleIdList></Reference><Reference><Citation>Sironi M., Biasin M., Cagliani R., Gnudi F., Saulle I., Ibba S., et al. (2014). Evolutionary Analysis Identifies an MX2 Haplotype Associated with Natural Resistance to HIV-1 Infection. Mol. Biol. Evol. 31 2402&#x2013;2414. 10.1093/molbev/msu193</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msu193</ArticleId><ArticleId IdType="pubmed">24930137</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares M., Eggelbusch M., Naddaf E., Gerrits K., Schaaf M., Borst B., et al. (2022). Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19. J. Cach. Sarcop. Muscle 13 11&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8818659</ArticleId><ArticleId IdType="pubmed">34997689</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A., Skriabine S., et al. (2021). Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 218 e20202135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S., Ramelli S., Grazioli A., Chung J., Singh M., Yinda C., et al. (2022). SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612 758&#x2013;763. 10.1038/s41586-022-05542-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#x119;pie&#x144; J., Pastuszak &#x17b;. (2023). Electroneurological changes in peripheral nerves in patients post-COVID. J. Neurophysiol. 129 392&#x2013;398. 10.1152/jn.00396.2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00396.2022</ArticleId><ArticleId IdType="pmc">PMC9902213</ArticleId><ArticleId IdType="pubmed">36515426</ArticleId></ArticleIdList></Reference><Reference><Citation>Taguchi M., Bonner K., Memon A. (2022). Late-Onset Guillain-Barr&#xe9; Syndrome and Right Facial Nerve Palsy after COVID-19 Infection. Case Rep. Neurol. 14 12&#x2013;18. 10.1159/000521245</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000521245</ArticleId><ArticleId IdType="pmc">PMC8787560</ArticleId><ArticleId IdType="pubmed">35111031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y., Uchida K., Nakajima H., Guerrero A., Watanabe S., Hirai T., et al. (2013). Blockade of Interleukin 6 Signaling Improves the Survival Rate of Transplanted Bone Marrow Stromal Cells and Increases Locomotor Function in Mice With Spinal Cord Injury. J. Neuropathol. Exp. Neurol. 72 980&#x2013;993. 10.1097/NEN.0b013e3182a79de9</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3182a79de9</ArticleId><ArticleId IdType="pubmed">24042200</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiyagarajan N., Ferguson R., Subramanian V., Acharya K. (2012). Structural and molecular insights into the mechanism of action of human angiogenin-ALS variants in neurons. Nat. Commun. 3:1121. 10.1038/ncomms2126</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2126</ArticleId><ArticleId IdType="pmc">PMC3493651</ArticleId><ArticleId IdType="pubmed">23047679</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasoni D., Bai F., Castoldi R., Barbanotti D., Falcinella C., Mul&#xe8; G., et al. (2021). Anxiety and depression symptoms after virological clearance of COVID-19: A cross-sectional study in Milan, Italy. J. Med. Virol. 93 1175&#x2013;1179. 10.1002/jmv.26459</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26459</ArticleId><ArticleId IdType="pmc">PMC7461061</ArticleId><ArticleId IdType="pubmed">32841387</ArticleId></ArticleIdList></Reference><Reference><Citation>Torretta E., Garziano M., Poliseno M., Capitanio D., Biasin M., Santantonio T., et al. (2021). Severity of COVID-19 patients predicted by serum sphingolipids signature. Int. J. Mol. Sci. 22:10198. 10.3390/ijms221910198</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910198</ArticleId><ArticleId IdType="pmc">PMC8508132</ArticleId><ArticleId IdType="pubmed">34638539</ArticleId></ArticleIdList></Reference><Reference><Citation>Valeri A., Chiricosta L., Calcaterra V., Biasin M., Cappelletti G., Carelli S., et al. (2021). Transcriptomic analysis of HCN-2 cells suggests connection among oxidative stress, senescence, and neuron death after SARS-CoV-2 infection. Cells 10:2189. 10.3390/cells10092189</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10092189</ArticleId><ArticleId IdType="pmc">PMC8472605</ArticleId><ArticleId IdType="pubmed">34571838</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo J., Sasaki M., Cho S., Kasuga Y., Zhu B., Ouda R., et al. (2021). SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis. Nat. Commun. 12:6602. 10.1038/s41467-021-26910-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26910-8</ArticleId><ArticleId IdType="pmc">PMC8594428</ArticleId><ArticleId IdType="pubmed">34782627</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Chu H., Han S., Shuai H., Deng J., Hu Y., et al. (2020). SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res. 30 928&#x2013;931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7399356</ArticleId><ArticleId IdType="pubmed">32753756</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H., Shen D., Zhou H., Liu J., Chen S. (2020). Guillain-Barr&#xe9; syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 19 383&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7176927</ArticleId><ArticleId IdType="pubmed">32246917</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L., Xu Z., Castiglione G., Soiberman U., Eberhart C., Duh E. (2020). ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Ocular Surf. 18 537&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7293510</ArticleId><ArticleId IdType="pubmed">32544566</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>